EU Orphan Designations Expected By Third Quarter; 24 Applications Received
Executive Summary
EMEA's Committee for Orphan Medicinal Products expects to deliver its first orphan drug designations by the third quarter of this year, the committee said.
You may also be interested in...
TKT European Company To Be Led By Ex-P&U Genotropin Team
Transkarayotic Therapies' newly established European company will be headed by executives who led the EU and Japan launch of Pharmacia & Upjohn's Genotropin.
TKT European Company To Be Led By Ex-P&U Genotropin Team
Transkarayotic Therapies' newly established European company will be headed by executives who led the EU and Japan launch of Pharmacia & Upjohn's Genotropin.
EMEA Should Adopt More FDA Methods To Speed Drug Approval - CPMP Chair
The European Medicines Evaluation Agency should consider the adoption of more FDA-style mechanisms to speed approval of important new drugs, Commission for Proprietary Medicinal Products Chairman Jean-Michel Alexandre, PhD, indicated.